The Advertising Standards Authority (ASA) bans advertisements for at-home testosterone test kits by online healthcare provider Voy after finding the ads made misleading claims. The ASA says the adverts were not adequately substantiated and could mislead consumers about low testosterone, including symptoms and how commonly it affects men.
The BBC reports the regulator’s decision focuses on the adverts’ claims about low testosterone and frames the ruling as part of its scrutiny of online healthcare advertising. The Telegraph similarly reports that the ads are banned, emphasising that the complaints involve assertions about low sex drive and the prevalence of low testosterone. Both outlets describe Voy as being required to stop the ads, reflecting the regulator’s view that the marketing could lead people to misunderstand their symptoms and the likelihood of the condition.